57 Furthermore, a subsequent prespecified analysis of the trial examined the effects of semaglutide in patients with and without history of HF at enrolment, with a significant reduction in MACE in patients with HFrEF and HFpEF and a 21% and 25% reduction in the HF composite endpoint, respectively
Maintenance is typically discussed after youve been on the medication long enough to reach a stable weight, and your provider can decide whether you should stay on your current dose or adjust it
Dinh Tran, MD What are GLP-1 injections, and how do they work for weight loss
Despite promising research, it is important to exercise caution when considering the potential benefits of GLP-1 agonists beyond diabetes and obesity
The 0.3% pancreatitis rate in trials, while low, represents a real concern for those with prior episodes